Found: 31
Select item for more details and to access through your institution.
The association between proton‐pump inhibitor use and recurrence of hepatocellular carcinoma after hepatectomy.
- Published in:
- Journal of Gastroenterology & Hepatology, 2024, v. 39, n. 10, p. 2077, doi. 10.1111/jgh.16640
- By:
- Publication type:
- Article
Mechanisms of the prevention and inhibition of the progression and development of non-alcoholic steatohepatitis by genetic and pharmacological decoy receptor 3 supplementation.
- Published in:
- Hepatology Research, 2017, v. 47, n. 12, p. 1260, doi. 10.1111/hepr.12863
- By:
- Publication type:
- Article
Concomitant inhibition of oxidative stress and angiogenesis by chronic hydrogen-rich saline and N-acetylcysteine treatments improves systemic, splanchnic and hepatic hemodynamics of cirrhotic rats.
- Published in:
- Hepatology Research, 2015, v. 45, n. 5, p. 578, doi. 10.1111/hepr.12379
- By:
- Publication type:
- Article
High carriage rate of extended‐spectrum β‐lactamase Enterobacterales and diarrheagenic Escherichia coli in healthy donor screening for fecal microbiota transplantation.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2023, v. 42, n. 9, p. 1103, doi. 10.1007/s10096-023-04644-3
- By:
- Publication type:
- Article
Determinants of Survival and Post-Progression Outcomes by Sorafenib–Regorafenib Sequencing for Unresectable Hepatocellular Carcinoma.
- Published in:
- Cancers, 2022, v. 14, n. 8, p. 2014, doi. 10.3390/cancers14082014
- By:
- Publication type:
- Article
Predictors of Response and Survival in Immune Checkpoint Inhibitor-Treated Unresectable Hepatocellular Carcinoma.
- Published in:
- Cancers, 2020, v. 12, n. 1, p. 182, doi. 10.3390/cancers12010182
- By:
- Publication type:
- Article
Active Vitamin D<sub>3</sub> Treatment Attenuated Bacterial Translocation via Improving Intestinal Barriers in Cirrhotic Rats.
- Published in:
- Molecular Nutrition & Food Research, 2021, v. 65, n. 3, p. 1, doi. 10.1002/mnfr.202000937
- By:
- Publication type:
- Article
Benzodiazepine-Associated Hepatic Encephalopathy Significantly Increased Healthcare Utilization and Medical Costs of Chinese Cirrhotic Patients: 7-Year Experience.
- Published in:
- Digestive Diseases & Sciences, 2014, v. 59, n. 7, p. 1603, doi. 10.1007/s10620-013-3021-2
- By:
- Publication type:
- Article
Impact of nutritional support routes on mortality in acute pancreatitis: A network meta‐analysis of randomized controlled trials.
- Published in:
- Journal of Internal Medicine, 2024, v. 295, n. 6, p. 759, doi. 10.1111/joim.13782
- By:
- Publication type:
- Article
Mac-2-Binding Protein Glycosylation Isomer to Albumin Ratio Predicts Bacterial Infections in Cirrhotic Patients.
- Published in:
- Digestive Diseases, 2024, v. 42, n. 2, p. 166, doi. 10.1159/000535325
- By:
- Publication type:
- Article
Application and Impact of Antiviral Therapy for Patients with HBV-Related Hepatocellular Carcinoma Receiving Sorafenib and Lenvatinib Treatment.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 11, p. 2355, doi. 10.3390/v14112355
- By:
- Publication type:
- Article
Outcomes of patients with malignant duodenal obstruction after receiving self-expandable metallic stents: A single center experience.
- Published in:
- PLoS ONE, 2022, v. 17, n. 5, p. 1, doi. 10.1371/journal.pone.0268920
- By:
- Publication type:
- Article
Assuring safety of fecal microbiota transplantation in the COVID‐19 era: A single‐center experience.
- Published in:
- JGH Open, 2023, v. 7, n. 11, p. 765, doi. 10.1002/jgh3.12979
- By:
- Publication type:
- Article
Durable objective response to sorafenib and role of sequential treatment in unresectable hepatocellular carcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221099401
- By:
- Publication type:
- Article
Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211010937
- By:
- Publication type:
- Article
Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211010937
- By:
- Publication type:
- Article
Lenvatinib plus pembrolizumab for systemic therapy-naïve and -experienced unresectable hepatocellular carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 11, p. 2631, doi. 10.1007/s00262-022-03185-6
- By:
- Publication type:
- Article
Antiplatelet Therapy is Associated with a Better Prognosis for Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma after Liver Resection.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2016, v. 23, p. 874, doi. 10.1245/s10434-016-5520-9
- By:
- Publication type:
- Article
The impact of clinically significant portal hypertension on the prognosis of patients with hepatocellular carcinoma after radiofrequency ablation: a propensity score matching analysis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Early Antibiotic Exposure Is Not Detrimental to Therapeutic Effect from Immunotherapy in Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 6, p. 583, doi. 10.1159/000519108
- By:
- Publication type:
- Article
Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma.
- Published in:
- Clinical & Molecular Hepatology, 2024, v. 30, n. 3, p. 406, doi. 10.3350/cmh.2024.0103
- By:
- Publication type:
- Article
Prophylactic clipping after endoscopic mucosal resection of large nonpedunculated colorectal lesions: A meta‐analysis.
- Published in:
- Journal of Gastroenterology & Hepatology, 2021, v. 36, n. 7, p. 1778, doi. 10.1111/jgh.15472
- By:
- Publication type:
- Article
Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study.
- Published in:
- Liver International, 2023, v. 43, n. 3, p. 695, doi. 10.1111/liv.15502
- By:
- Publication type:
- Article
Validation of the albumin‐bilirubin grade‐based integrated model as a predictor for sorafenib‐failed hepatocellular carcinoma.
- Published in:
- Liver International, 2018, v. 38, n. 2, p. 321, doi. 10.1111/liv.13527
- By:
- Publication type:
- Article
Pre-sarcopenia determines post-progression outcomes in advanced hepatocellular carcinoma after sorafenib failure.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-75198-z
- By:
- Publication type:
- Article
Comparative portal hypotensive effects as propranolol of vitamin D<sub>3</sub> treatment by decreasing intrahepatic resistance in cirrhotic rats.
- Published in:
- Journal of Gastroenterology & Hepatology, 2015, v. 30, n. 3, p. 628, doi. 10.1111/jgh.12721
- By:
- Publication type:
- Article
Beneficial effects of dual vascular endothelial growth factor receptor/fibroblast growth factor receptor inhibitor brivanib alaninate in cirrhotic portal hypertensive rats.
- Published in:
- Journal of Gastroenterology & Hepatology, 2014, v. 29, n. 5, p. 1073, doi. 10.1111/jgh.12480
- By:
- Publication type:
- Article
Triage policy to postpone endoscopy for patients with low-risk varices is safe during the lockdown period of COVID-19 pandemic.
- Published in:
- BMC Gastroenterology, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12876-023-02866-5
- By:
- Publication type:
- Article
Effectiveness of betadine-coating gastrostomy tube to reduce peristomal infection after percutaneous endoscopic gastrostomy: a randomized controlled trial.
- Published in:
- BMC Gastroenterology, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12876-023-02702-w
- By:
- Publication type:
- Article
Anti- VEGFR agents ameliorate hepatic venous dysregulation/microcirculatory dysfunction, splanchnic venous pooling and ascites of NASH-cirrhotic rat.
- Published in:
- Liver International, 2014, v. 34, n. 4, p. 521, doi. 10.1111/liv.12299
- By:
- Publication type:
- Article
Down-regulation of common NFκB-iNOS pathway by chronic Thalidomide treatment improves Hepatopulmonary Syndrome and Muscle Wasting in rats with Biliary Cirrhosis.
- Published in:
- Scientific Reports, 2016, p. 39405, doi. 10.1038/srep39405
- By:
- Publication type:
- Article